Synthesis and In Vitro Anti-Cancer Evaluation of Ethylene Glycol-Saponin Loaded on Magnetic Nanoparticles
Prostate cancer is one of the most preventable cancers, yet effective therapeutics, especially targeted therapy, are still lacking. Saponin has been reported to possess various biological properties such as anti-cancer and anti-inflammatory activity. In this study, the anti-tumor activity of magnetic nanoparticles loaded with ethylene glycol and a saponin complex (ESMP) against DU145 prostate cancer cells was examined. Composite nanoparticles with an average size of 23 nm were prepared using a chemical co-precipitation technique. The ESMP were cytotoxic to DU145 cells and specifically inhibited cell proliferation. In contrast, the magnetic nanoparticles by themselves showed no significant cytotoxicity. The expression levels of the angiogenesis related proteins, including phospho-extracellular signal-regulated kinase, p38 and pAKT, decreased after ESMP treatment. This study highlights the therapeutic potential of using ESMP for targeted-therapy against prostate cancer.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
Document Type: Research Article
Publication date: 2010-10-01
More about this publication?
- Journal for Nanoscience and Nanotechnology (JNN) is an international and multidisciplinary peer-reviewed journal with a wide-ranging coverage, consolidating research activities in all areas of nanoscience and nanotechnology into a single and unique reference source. JNN is the first cross-disciplinary journal to publish original full research articles, rapid communications of important new scientific and technological findings, timely state-of-the-art reviews with author's photo and short biography, and current research news encompassing the fundamental and applied research in all disciplines of science, engineering and medicine.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites